ZA202109175B - Novel peptide compound or pharmaceutically acceptable salt thereof - Google Patents
Novel peptide compound or pharmaceutically acceptable salt thereofInfo
- Publication number
- ZA202109175B ZA202109175B ZA2021/09175A ZA202109175A ZA202109175B ZA 202109175 B ZA202109175 B ZA 202109175B ZA 2021/09175 A ZA2021/09175 A ZA 2021/09175A ZA 202109175 A ZA202109175 A ZA 202109175A ZA 202109175 B ZA202109175 B ZA 202109175B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- peptide compound
- novel peptide
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/55—Peptide, protein hydrolysate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190059628 | 2019-05-21 | ||
| PCT/KR2020/006594 WO2020235932A1 (ko) | 2019-05-21 | 2020-05-20 | 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202109175B true ZA202109175B (en) | 2024-04-24 |
Family
ID=73458705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2021/09175A ZA202109175B (en) | 2019-05-21 | 2021-11-17 | Novel peptide compound or pharmaceutically acceptable salt thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12428446B2 (https=) |
| EP (2) | EP3974441B1 (https=) |
| JP (1) | JP7576048B2 (https=) |
| KR (2) | KR20200134175A (https=) |
| CN (1) | CN114269769B (https=) |
| AU (1) | AU2020277930B2 (https=) |
| BR (1) | BR112021023477A2 (https=) |
| CA (1) | CA3139411A1 (https=) |
| ES (1) | ES3012499T3 (https=) |
| MX (1) | MX2021014051A (https=) |
| MY (1) | MY205382A (https=) |
| PL (1) | PL3974441T3 (https=) |
| SG (1) | SG11202112276RA (https=) |
| WO (1) | WO2020235932A1 (https=) |
| ZA (1) | ZA202109175B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| EP4450079A4 (en) * | 2021-12-13 | 2025-12-10 | Eyebiokorea Inc | COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE |
| KR20230089987A (ko) | 2021-12-14 | 2023-06-21 | 주식회사 아이바이오코리아 | 펩타이드 약물을 포함하는 안구 투여용 약학 조성물 |
| WO2023224454A1 (ko) | 2022-05-20 | 2023-11-23 | 주식회사 엘지화학 | 양극 활물질 및 이의 제조방법 |
| KR102587729B1 (ko) | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
| KR102728422B1 (ko) * | 2024-05-27 | 2024-11-11 | 주식회사 아이바이오코리아 | 염증성 질환의 치료 효과를 갖는 신규한 펩타이드 및 이의 용도 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084555A (en) | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
| IT1241761B (it) * | 1990-08-03 | 1994-02-01 | Menarini Farma Ind | Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione |
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2004074312A2 (en) * | 2003-02-05 | 2004-09-02 | University Of Ulster | Tryptophyllin peptides and uses thereof |
| NZ577196A (en) | 2005-01-20 | 2011-06-30 | Biomarck Pharmaceuticals Ltd | Mucin hypersecretion inhibitors based on the structure of MANS and methods of use |
| US8378070B2 (en) | 2007-03-12 | 2013-02-19 | Ramot At Tel-Aviv University Ltd. | Peptides for the regulation of neurotransmitter sequestration and release |
| AU2008297541A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| US20090074672A1 (en) | 2007-09-17 | 2009-03-19 | Sri International | Tumor Boundary Imaging |
| JP5299956B2 (ja) | 2008-09-29 | 2013-09-25 | 国立大学法人東北大学 | 質量分析装置を用いた代謝酵素群の一斉タンパク質定量に用いるペプチド |
| WO2011060349A1 (en) | 2009-11-13 | 2011-05-19 | North Carolina State University | Methods of modulating mesenchymal stem cells |
| CA2869599C (en) * | 2012-04-13 | 2021-07-27 | Lubrizol Advanced Materials, Inc. | Compounds which inhibit neuronal exocytosis (ii) |
| WO2013158230A1 (en) | 2012-04-19 | 2013-10-24 | The Regents Of The University Of California | Compositions and methods for detecting unstable arteriosclerotic plaques |
| KR101438744B1 (ko) | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| KR101721059B1 (ko) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101810163B1 (ko) | 2016-04-08 | 2018-01-25 | 주식회사 아이바이오코리아 | 안구 표면질환 예방 또는 치료용 약학조성물 |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| EP3539559B1 (en) | 2016-04-08 | 2020-08-26 | Eyebio Korea | Collagen type ii alpha-1-based peptide for use in the treatment of macular degeneration |
| KR101795650B1 (ko) | 2016-05-12 | 2017-11-09 | 인제대학교 산학협력단 | 아플리버셉트-콜라겐 타입 ii 펩타이드의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR101795653B1 (ko) | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| JP2019524673A (ja) * | 2016-06-28 | 2019-09-05 | バロリゼーション−ルシェルシュ，リミテッド パートナーシップ | 新規な環状ペプチドおよびその使用 |
| HUP1700012A2 (en) * | 2017-01-06 | 2018-07-30 | Evolveritas Kft | Novel proteins and use thereof |
| EP3609519B1 (en) * | 2017-04-11 | 2025-11-26 | University of Maryland, Baltimore | Compositions and methods for treating inflammation and cancer |
| RU2766160C2 (ru) * | 2017-05-17 | 2022-02-08 | Юю Фарма, Инк. | Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента |
| CN107814840B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽pkypvepf及其制备方法和应用 |
| CN108727472A (zh) * | 2018-06-07 | 2018-11-02 | 南方医科大学 | 带负电荷的细胞穿透肽及作为细胞内运送载体的用途 |
| TWI865470B (zh) | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
-
2020
- 2020-05-20 BR BR112021023477A patent/BR112021023477A2/pt unknown
- 2020-05-20 KR KR1020200060397A patent/KR20200134175A/ko not_active Ceased
- 2020-05-20 JP JP2021568962A patent/JP7576048B2/ja active Active
- 2020-05-20 PL PL20808771.8T patent/PL3974441T3/pl unknown
- 2020-05-20 AU AU2020277930A patent/AU2020277930B2/en active Active
- 2020-05-20 EP EP20808771.8A patent/EP3974441B1/en active Active
- 2020-05-20 CN CN202080037370.6A patent/CN114269769B/zh active Active
- 2020-05-20 WO PCT/KR2020/006594 patent/WO2020235932A1/ko not_active Ceased
- 2020-05-20 ES ES20808771T patent/ES3012499T3/es active Active
- 2020-05-20 CA CA3139411A patent/CA3139411A1/en active Pending
- 2020-05-20 MX MX2021014051A patent/MX2021014051A/es unknown
- 2020-05-20 US US17/613,176 patent/US12428446B2/en active Active
- 2020-05-20 SG SG11202112276RA patent/SG11202112276RA/en unknown
- 2020-05-20 EP EP24210365.3A patent/EP4483959A3/en active Pending
- 2020-05-20 MY MYPI2021006829A patent/MY205382A/en unknown
-
2021
- 2021-11-17 ZA ZA2021/09175A patent/ZA202109175B/en unknown
-
2022
- 2022-04-29 KR KR1020220053844A patent/KR102523943B1/ko active Active
-
2024
- 2024-06-27 US US18/756,527 patent/US20240352071A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7576048B2 (ja) | 2024-10-30 |
| EP4483959A3 (en) | 2025-06-04 |
| EP4483959A2 (en) | 2025-01-01 |
| SG11202112276RA (en) | 2021-12-30 |
| KR102523943B1 (ko) | 2023-04-20 |
| CN114269769B (zh) | 2024-12-06 |
| EP3974441A1 (en) | 2022-03-30 |
| PL3974441T3 (pl) | 2025-04-07 |
| EP3974441B1 (en) | 2024-12-04 |
| KR20200134175A (ko) | 2020-12-01 |
| EP3974441A4 (en) | 2023-10-18 |
| CA3139411A1 (en) | 2020-11-26 |
| ES3012499T3 (en) | 2025-04-09 |
| WO2020235932A1 (ko) | 2020-11-26 |
| BR112021023477A2 (pt) | 2022-02-15 |
| US20240228538A1 (en) | 2024-07-11 |
| KR20220062252A (ko) | 2022-05-16 |
| US12428446B2 (en) | 2025-09-30 |
| JP2022533991A (ja) | 2022-07-27 |
| MX2021014051A (es) | 2022-02-11 |
| AU2020277930B2 (en) | 2024-06-13 |
| CN114269769A (zh) | 2022-04-01 |
| US20240352071A1 (en) | 2024-10-24 |
| MY205382A (en) | 2024-10-18 |
| AU2020277930A1 (en) | 2021-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202109175B (en) | Novel peptide compound or pharmaceutically acceptable salt thereof | |
| ZA202206923B (en) | New methylquinazolinone derivatives | |
| PH12020500673A1 (en) | Compounds | |
| MY197700A (en) | Compounds useful for inhibiting cdk7 | |
| PH12021552150A1 (en) | Anti-il36r antibody formulations | |
| PH12021550102A1 (en) | Cardiosafe antidiabetic therapy | |
| ZA202007737B (en) | Pentacyclic compound | |
| MX2018001517A (es) | Derivados sustituidos de guanidina. | |
| PH12021550452A1 (en) | Methods of treating mycobacterial infections using tetracycline compounds | |
| PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| MY193239A (en) | Novel b-lactamase inhibitors | |
| EP4049680A4 (en) | NEW SUBSTITUTED CONDENSED RING CONNECTION | |
| SG11201803867TA (en) | Sodium channel blocker | |
| ZA202205170B (en) | Process and intermediate for the preparation of oxetan-2-ylmethanamine | |
| MX2020008689A (es) | Composicion herbicida que comprende por lo menos un compuesto activo fenolico. | |
| ZA202105425B (en) | A novel compound derived from allulose | |
| EP3978511A4 (en) | NOROVIRUS BINDING PEPTIDE | |
| GB201918693D0 (en) | Peptide | |
| ZA202205158B (en) | Polypeptide having mmp2-inhibitory effect | |
| WO2020055360A3 (en) | The parenteral composition comprising carfilzomib | |
| EP3995506A4 (en) | NOROVIRUS BINDING PEPTIDE | |
| MY208423A (en) | Composition of aminopyran derivative | |
| TR201721065A2 (tr) | Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar | |
| SA119400353B1 (ar) | مشتق بيرازول مستبدل | |
| HK40077506A (zh) | Q-er肽 |